164 related articles for article (PubMed ID: 28029685)
1. Immunoprofile of metaplastic carcinomas of the breast.
Rakha EA; Coimbra ND; Hodi Z; Juneinah E; Ellis IO; Lee AH
Histopathology; 2017 May; 70(6):975-985. PubMed ID: 28029685
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.
Dunne B; Lee AH; Pinder SE; Bell JA; Ellis IO
Hum Pathol; 2003 Oct; 34(10):1009-15. PubMed ID: 14608534
[TBL] [Abstract][Full Text] [Related]
3. Metaplastic carcinoma of the breast: an immunohistochemical study.
Altaf FJ; Mokhtar GA; Emam E; Bokhary RY; Mahfouz NB; Al Amoudi S; Al-Gaithy ZK
Diagn Pathol; 2014 Jul; 9():139. PubMed ID: 25030022
[TBL] [Abstract][Full Text] [Related]
4. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.
D'Alfonso TM; Ross DS; Liu YF; Shin SJ
J Clin Pathol; 2015 Jul; 68(7):516-21. PubMed ID: 25795733
[TBL] [Abstract][Full Text] [Related]
5. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
Nassar A; Sussman ZM; Lawson D; Cohen C
Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
[TBL] [Abstract][Full Text] [Related]
6. Metaplastic breast carcinomas are basal-like tumours.
Reis-Filho JS; Milanezi F; Steele D; Savage K; Simpson PT; Nesland JM; Pereira EM; Lakhani SR; Schmitt FC
Histopathology; 2006 Jul; 49(1):10-21. PubMed ID: 16842242
[TBL] [Abstract][Full Text] [Related]
7. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
8. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.
Leibl S; Gogg-Kammerer M; Sommersacher A; Denk H; Moinfar F
Am J Surg Pathol; 2005 Mar; 29(3):347-53. PubMed ID: 15725803
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.
Yamaguchi R; Tanaka M; Kondo K; Yokoyama T; Maeda I; Tsuchiya S; Yamaguchi M; Takahashi R; Ogata Y; Abe H; Akiba J; Nakashima O; Kage M; Yano H
Med Mol Morphol; 2012 Dec; 45(1):14-21. PubMed ID: 22431179
[TBL] [Abstract][Full Text] [Related]
10. Cell blocks allow reliable evaluation of expression of basal (CK5/6) and luminal (CK8/18) cytokeratins and smooth muscle actin (SMA) in breast carcinoma.
Delgallo WD; Rodrigues JR; Bueno SP; Viero RM; Soares CT
Cytopathology; 2010 Aug; 21(4):259-66. PubMed ID: 19843143
[TBL] [Abstract][Full Text] [Related]
11. Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients.
Adem C; Reynolds C; Adlakha H; Roche PC; Nascimento AG
Histopathology; 2002 Jun; 40(6):556-62. PubMed ID: 12047767
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of Metaplastic Breast Carcinoma: Keratin OSCAR Versus Other Cytokeratins.
Galera P; Khan A; Kandil D
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):622-626. PubMed ID: 26371435
[TBL] [Abstract][Full Text] [Related]
13. Best Practice (Efficient) Immunohistologic Panel for Diagnosing Metaplastic Breast Carcinoma.
Han M; Zhang H; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):265-269. PubMed ID: 32858538
[TBL] [Abstract][Full Text] [Related]
14. [Matrix-producing breast carcinoma with myoepithelial differentiation--description of 11 cases and review of literature aimed at histogenesis and differential diagnosis].
Kinkor Z; Boudová L; Ryska A; Kajo K; Svec A
Ceska Gynekol; 2004 May; 69(3):229-36. PubMed ID: 15310000
[TBL] [Abstract][Full Text] [Related]
15. Benign phyllodes tumor of the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma.
Muller KE; Tafe LJ; de Abreu FB; Peterson JD; Wells WA; Barth RJ; Marotti JD
Hum Pathol; 2015 Feb; 46(2):327-33. PubMed ID: 25476122
[TBL] [Abstract][Full Text] [Related]
16. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
Leibl S; Moinfar F
Am J Surg Pathol; 2006 Apr; 30(4):450-6. PubMed ID: 16625090
[TBL] [Abstract][Full Text] [Related]
17. TROP2, androgen receptor, and PD-L1 status in histological subtypes of high-grade metaplastic breast carcinomas.
Chartier S; Brochard C; Martinat C; Coussy F; Feron JG; Kirova Y; Cottu P; Marchiò C; Vincent-Salomon A
Histopathology; 2023 Apr; 82(5):664-671. PubMed ID: 36527253
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
Barnes PJ; Boutilier R; Chiasson D; Rayson D
Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
[TBL] [Abstract][Full Text] [Related]
19. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
20. Mesothelial markers in high-grade breast carcinoma.
Duhig EE; Kalpakos L; Yang IA; Clarke BE
Histopathology; 2011 Nov; 59(5):957-64. PubMed ID: 22092407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
